Contac Severe Cold and Flu is a product of GlaxoSmithKline plc. How should GSK investment this brand in china

Contac Severe Cold and Flu
Author Name
University Name
Introduction
Contac Severe Cold and Flu, manufactured and distributed by GlaxoSmithKline, is primarily a fever reducer and pain reliever. In some circumstances, the drug is used to cure conditions like arthritis, flu, backache, headache, toothache, muscle aches and cold. In the United States, Contac Severe Cold and Flu has long been used as a productive cough suppressant. It can even prevent the production of harmful chemicals, especially histamine in the human body. Anyone with a wet nose and eyes, allergy, and vomiting can use a Contac Severe Cold and Flu after the recommendation of his doctor. Phenylpropanolamine, one of the primary ingredients of this product, is often associated with increased risks of cardiac arrest and hemorrhagic stroke in both men and women. However, according to the U.S. Food and Drug Administration (FDA), Contac Severe Cold and Flu is health-friendly and contains phenylpropanolamine in a very low amount (Tucker, 2006).
China, the manufacturing powerhouse in the world, has continued its movement toward a value-add economy and the major industry of this state is healthcare. A large number of foreigners invest heavily in China’s health projects, and this is a good opportunity for GlaxoSmithKline to target some of the most diversified and established Chinese markets for Contac Severe Cold and Flu. As this country has rocketed into its position as one of the major economies in a few years under strict policies and rules and regulations, GlaxoSmithKline would have to maintain the quality of its pharmaceutical drug to generate more and more revenues (Choi, 2012).
Product Introduction Strategy
It may not be possible for GlaxoSmithKline to introduce Contac Severe Cold and Flu in China and make an everlasting impression in a few days. The pharmaceutical company would definitely have to market or promote it well and let the Chinese know about its significance. It should be noticed that entering the international markets is not only complicated but also costly. In China, where the competition among pharmaceutical companies is already high, and the consumers have become choosy, GlaxoSmithKline would need to take serious, practical measures. The first thing they should pay attention is to pricing Contac Severe Cold and Flu wisely (El-Awady, 2015).
In China, the average price of a pill is $10 to $20 depending on its nature and the type of disease it is being used for. The company cannot afford to charge too much until or unless its reputation is built within the country. It’s safe to say that seasons greatly impact sales in China, so the company should be clear about when they want to launch Contac Severe Cold and Flu in the Chinese markets. Single’s Day or Chinese New Year can be the best time to promote the drug through television advertisements and social media campaigns, letting Chinese know that an effective medication has just been launched that will help treat a cough, flu, cold, fever, headache and other similar complications (Choi, 2012).
Methods for Marketing and Distribution
The possibility of selling in China has become increasingly difficult because both large-sized and medium-sized companies are already opera...